Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Financial Results for the third quarter and nine months ended December 31, 2023, for the financial year 2023-24, published in the newspaper on February 6, 2024.
06-02-2024
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Results For Quarter And Nine Months Ended December 31, 2023.

Results for quarter and nine months ended December 31, 2023.
05-02-2024
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

Unichem Laboratories Limited has approved the issuance of a Letter of Confirmation on January 15, 2024, in lieu of the share certificate which was reported lost by the Shareholder.
17-01-2024
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Board Meeting Intimation for Unaudited Financial Results For Quarter And Nine Months Ended December 31., 2023

UNICHEM LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2024 ,inter alia, to consider and approve Unaudited financial results for quarter and nine months ended December 31., 2023
15-01-2024

Unichem Laboratories hit 52-week high on USFDA nod for hypertension drug

The company will manufacture doxazosin tablets, a generic version of Cardura of Viatris Specialty, at its Goa plant
11-01-2024
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Press Release - ANDA approval from the USFDA for Unichem''s Doxazosin.
11-01-2024
Bigul

UNICHEM LABORATORIES LTD. - 506690 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

Compliance Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018 for quarter ended December 31, 2023.
09-01-2024
Bigul

Stock to buy today: Unichem Laboratories (454.70): BUY

Unichem Laboratories share price can rise to 500
09-01-2024
Next Page
Close

Let's Open Free Demat Account